Agilon Health Analyst Ratings
Agilon Health Holds Steady: A Balanced Analysis of Performance and Uncertainties
Agilon Health Analyst Ratings
Agilon Health Price Target Maintained With a $8.00/Share by RBC Capital
Agilon Health Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Agilon Health (AGL)
Agilon Health (AGL) Gets a Hold From Evercore ISI
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)
Maintaining Buy Rating on Agilon Health Amidst Strategic Growth and Financial Resilience
TD Cowen Reaffirms Their Hold Rating on Agilon Health (AGL)
Agilon Health Analyst Ratings
Agilon Health Analyst Ratings
Agilon Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Merus (MRUS) and Agilon Health (AGL)
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Agilon Health (AGL) and Boston Scientific (BSX)
Agilon Health: Maintaining Hold Amid Improved EBITDA and Persistent Financial Uncertainties
Agilon Health Maintains Buy Rating Amidst Positive Outlook and Cost Management Efficacy
Agilon Health (AGL) Gets a Sell From Barclays
Stifel Nicolaus Reaffirms Their Hold Rating on Agilon Health (AGL)
Agilon Health Analyst Ratings
No Data